MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.84 -0.13 (-0.93%)
As of: Sep 4, 2026 · 3:12 PM EDT

MeiraGTx Holdings (MGTX) EBITDA (2017 - 2026)

MeiraGTx Holdings' (MGTX) quarterly EBITDA came in at $18.2 million in Q4 2025, up 157.92% YoY from $7.1 million in Q4 2024, and up 139.61% on a QoQ basis from -$46.1 million in Q3 2025.

Analysis

MeiraGTx Holdings (MGTX) EBITDA (2017 - 2026) Analysis & Trends

MeiraGTx Holdings (MGTX) has 9 years of EBITDA data on file, last reported at $18.2 million in Q4 2025.

  • Quarterly EBITDA rose 157.92% year-over-year to $18.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$106.6 million (up 35.87% YoY) and the FY2025 annual result came in at -$114.2 million, up 30.46% from the prior year.
  • EBITDA climbed to $18.2 million in Q4 2025, from -$46.1 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $18.2 million in Q4 2025 to a low of -$48.6 million in Q2 2024.
  • A 5-year average of -$27.3 million and a median of -$30.1 million in 2023 frame the typical range for EBITDA.
  • Annual changes were most pronounced in 2024 — EBITDA plunged 439.33% — and 2025, when it soared 157.92%.
  • Tracing MGTX's EBITDA over 5 years: stood at -$7.7 million in 2021, then sank by 433.88% to -$41.1 million in 2022, then surged by 122.6% to $9.3 million in 2023, then sank by 439.33% to -$31.5 million in 2024, then soared by 157.92% to $18.2 million in 2025.
  • The last three EBITDA figures came in at $18.2 million (Q4 2025), -$46.1 million (Q3 2025), and -$38.8 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 1.29 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn 493.00 Mn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn -815.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn - -505.13 Mn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 325.05 Mn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 231.44 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn - 133.12 Mn
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -1.55 Mn
10 MeiraGTx Holdings 1.27 Bn 1.12 Bn 315.67 Mn 244.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 244.43 Mn
Dec 31, 2025 18.24 Mn
Sep 30, 2025 -50.51 Mn
Jun 30, 2025 -44.79 Mn
Mar 31, 2025 -41.60 Mn
Dec 31, 2024 -31.49 Mn
Sep 30, 2024 -40.04 Mn
Jun 30, 2024 -48.62 Mn
Mar 31, 2024 -46.77 Mn
Dec 31, 2023 -43.75 Mn
Sep 30, 2023 -32.76 Mn
Jun 30, 2023 -28.79 Mn
Mar 31, 2023 -31.76 Mn
Dec 31, 2022 -41.06 Mn
Sep 30, 2022 -22.81 Mn
Jun 30, 2022 -23.76 Mn
Mar 31, 2022 -28.73 Mn
Dec 31, 2021 -7.69 Mn
Sep 30, 2021 -22.55 Mn
Jun 30, 2021 -20.48 Mn